title: Decreased expression of alpha-L-fucosidase gene FUCA1 in human colorectal tumors.
abstract: In previous studies we described a decreased alpha-L-fucosidase activity in colorectal tumors, appearing as a prognostic factor of tumoral recurrence. The aim of this work was to extend the knowledge about tissue alpha-L-fucosidase in colorectal cancer by quantifying the expression of its encoding gene FUCA1 in tumors and healthy mucosa. FUCA1 mRNA levels were measured by RT-qPCR in paired tumor and normal mucosa tissues from 31 patients. For the accuracy of the RT-qPCR results, five candidate reference genes were validated in those samples. In addition, activity and expression of alpha-L-fucosidase in selected matched tumor and healthy mucosa samples were analyzed. According to geNorm and NormFinder algorithms, RPLP0 and HPRT1 were the best reference genes in colorectal tissues. These genes were used for normalization of FUCA1 expression levels. A significant decrease of more than 60% in normalized FUCA1 expression was detected in tumors compared to normal mucosa (p = 0.002). Moreover, a gradual decrease in FUCA1 expression was observed with progression of disease from earlier to advanced stages. These findings were confirmed by Western blot analysis of alpha-L-fucosidase expression. Our results demonstrated diminished FUCA1 mRNA levels in tumors, suggesting that expression of tissue alpha-L-fucosidase could be regulated at transcriptional level in colorectal cancer.
authors: Department of Biochemistry, Genetics and Immunology, University of Vigo, Campus As Lagoas Marcosende s/n, 36310 Vigo, Spain. olalla.otero@uvigo.es
authors: Olalla
authors: O
authors: Otero-Estévez
authors: Mónica
authors: M
authors: Martínez-Fernández
authors: Lorena
authors: L
authors: Vázquez-Iglesias
authors: María
authors: M
authors: Páez de la Cadena
authors: Francisco J
authors: FJ
authors: Rodríguez-Berrocal
authors: Vicenta S
authors: VS
authors: Martínez-Zorzano
mesh_terms: D000230:Adenocarcinoma / Q000201:enzymology* / Q000235:genetics; D000368:Aged; D000369:Aged, 80 and over; D015179:Colorectal Neoplasms / Q000201:enzymology* / Q000235:genetics; D017931:DNA Primers / Q000235:genetics / Q000592:standards; D004794:Enzyme Repression; D005260:Female; D015870:Gene Expression; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007413:Intestinal Mucosa / Q000201:enzymology; D008297:Male; D008875:Middle Aged; D060888:Real-Time Polymerase Chain Reaction; D012015:Reference Standards; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000592:standards; D005644:alpha-L-Fucosidase / Q000235:genetics / Q000378:metabolism*
chemical_list: D017931:DNA Primers; D005644:alpha-L-Fucosidase
references: Anal Biochem. 2005 Sep 1;344(1):141-3
references: 16054107
references: J Hum Genet. 2007;52(6):553-556
references: 17427030
references: Cancer Detect Prev. 2000;24(2):143-9
references: 10917134
references: Genome Biol. 2007;8(2):R19
references: 17291332
references: Lancet. 2010 Mar 20;375(9719):1030-47
references: 20304247
references: Eur J Gynaecol Oncol. 1983;4(2):135-8
references: 6873092
references: Hepatology. 1989 Feb;9(2):249-52
references: 2536349
references: Cancer Lett. 1997 Dec 23;121(2):147-53
references: 9570352
references: Tumour Biol. 2000 May-Jun;21(3):153-64
references: 10754466
references: J Exp Clin Cancer Res. 2010 Nov 08;29:144
references: 21059236
references: Gastroenterology. 2008 Jul;135(1):142-151.e3
references: 18485915
references: Int J Oncol. 1996 Oct;9(4):747-54
references: 21541579
references: Oncol Lett. 2010 Mar;1(2):361-366
references: 22966309
references: BMC Mol Biol. 2009 Mar 03;10:17
references: 19257903
references: BMC Cancer. 2009 Feb 06;9:49
references: 19200351
references: Cancer Res. 2004 Aug 1;64(15):5245-50
references: 15289330
references: Genome Biol. 2002 Jun 18;3(7):RESEARCH0034
references: 12184808
references: Acta Biochim Biophys Sin (Shanghai). 2010 Aug;42(8):568-74
references: 20705598
references: Clin Sci (Lond). 1991 Aug;81(2):177-82
references: 1716188
references: Glycoconj J. 2010 Oct;27(7-9):649-59
references: 20953699
references: PLoS One. 2011;6(8):e22301
references: 21857920
references: Epigenetics Chromatin. 2009 Jun 08;2(1):7
references: 19505295
references: Clin Proteomics. 2011 Jun 03;8(1):7
references: 21906357
references: Bioanalysis. 2012 Oct;4(20):2457-69
references: 23157355
references: PLoS One. 2009 Sep 15;4(9):e7045
references: 19753114
references: Genes Immun. 2005 Jun;6(4):279-84
references: 15815687
references: Clin Chem. 2010 Feb;56(2):223-36
references: 19959616
references: Comp Biochem Physiol B. 1991;99(3):479-88
references: 1769200
references: Gene. 2007 May 1;392(1-2):34-46
references: 17175120
references: Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10231-3
references: 12149519
references: Methods. 2001 Dec;25(4):402-8
references: 11846609
references: Int J Biochem Cell Biol. 1996 Jun;28(6):651-7
references: 8673729
references: BMC Res Notes. 2013 Feb 04;6:46
references: 23379847
references: Mol Aspects Med. 2006 Apr-Jun;27(2-3):95-125
references: 16460794
references: Clin Epigenetics. 2011 Aug;2(2):425-32
references: 22704355
references: J Proteome Res. 2009 Jun;8(6):2990-3005
references: 19292502
references: Mol Cell Proteomics. 2012 Sep;11(9):571-85
references: 22573871
references: Cancer Res. 1995 Aug 15;55(16):3654-8
references: 7627975
references: BMC Res Notes. 2009 Aug 19;2:164
references: 19689820